v3.26.1
Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Preferred Stock [Member]
Redeemable Preferred Stock [Member]
Preferred Stock [Member]
Series F Preferred Stock [Member]
Preferred Stock [Member]
Employees and Directors [Member]
Preferred Stock [Member]
Director [Member]
Preferred Stock [Member]
At the Market Offering Agreement [Member]
Preferred Stock [Member]
Common Stock [Member]
Series F Preferred Stock [Member]
 [1]
Common Stock [Member]
Employees and Directors [Member]
 [1]
Common Stock [Member]
Director [Member]
 [1]
Common Stock [Member]
At the Market Offering Agreement [Member]
 [1]
Common Stock [Member]
Additional Paid-in Capital [Member]
Series F Preferred Stock [Member]
 [1]
Additional Paid-in Capital [Member]
Employees and Directors [Member]
 [1]
Additional Paid-in Capital [Member]
Director [Member]
 [1]
Additional Paid-in Capital [Member]
At the Market Offering Agreement [Member]
 [1]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Series F Preferred Stock [Member]
Retained Earnings [Member]
Employees and Directors [Member]
Retained Earnings [Member]
Director [Member]
Retained Earnings [Member]
At the Market Offering Agreement [Member]
Retained Earnings [Member]
Series F Preferred Stock [Member]
The 2024 Warrant Reprice Transaction [Member]
Employees and Directors [Member]
Director [Member]
At the Market Offering Agreement [Member]
Total
Balance (in shares) at Dec. 31, 2024           1,000         977,000 [1]                                
Balance at Dec. 31, 2024           $ 6         $ 10 [1]         $ 183,312 [1]         $ (183,457)           $ (129)
Net income (loss)           $ 0         $ 0 [1]         0 [1]         7,670           7,670
Exercise of warrants (in shares)           0         186,000 [1]                                
Exercise of warrants           $ 0         $ 2 [1]         612 [1]         0           614
Stock-based compensation expense                     $ 0 [1]         2 [1]         0           2
Balance (in shares) at Mar. 31, 2025           1,000         1,163,000 [1]                                
Balance at Mar. 31, 2025           $ 6         $ 12 [1]         181,936 [1]         (175,787)           6,167
Repurchase of warrants                     $ 0 [1]         (1,990) [1]         0           (1,990)
Balance (in shares) at Dec. 31, 2024           1,000         977,000 [1]                                
Balance at Dec. 31, 2024           $ 6         $ 10 [1]         183,312 [1]         (183,457)           (129)
Net income (loss)                                                     5,748
Balance (in shares) at Jun. 30, 2025           1,000         1,164,000 [1]                                
Balance at Jun. 30, 2025           $ 6         $ 12 [1]         181,936 [1]         (177,709)           4,245
Balance (in shares) at Mar. 31, 2025           1,000         1,163,000 [1]                                
Balance at Mar. 31, 2025           $ 6         $ 12 [1]         181,936 [1]         (175,787)           6,167
Net income (loss)           $ 0         $ 0 [1]         0 [1]         (1,922)           (1,922)
Stock-based compensation expense     $ 0         $ 0         $ 1         $ 0           $ 1      
Balance (in shares) at Jun. 30, 2025           1,000         1,164,000 [1]                                
Balance at Jun. 30, 2025           $ 6         $ 12 [1]         181,936 [1]         (177,709)           4,245
Repurchase of warrants           $ 0         $ 0 [1]         (1) [1]         0           (1)
Vesting of director restricted stock awards (in shares)       0         1,000                                    
Vesting of director restricted stock awards       $ 0         $ 0         $ 0         $ 0           $ 0    
Balance (in shares) at Dec. 31, 2025 1,347,000         1,000         25,216,000 [1]                                
Balance at Dec. 31, 2025 $ 350         $ 6         $ 252 [1]         186,981 [1]         (819,054)           (631,815)
Net income (loss)           $ 0         $ 0 [1]         0 [1]         552,403           552,403
Redemption of Series F Preferred Stock (in shares)   (1,347,000)         0                                        
Redemption of Series F Preferred Stock   $ (350)         $ 0         $ 0         $ 0         $ 0          
Conversion of Preferred Stock to common stock (in shares)           0         7,000 [1]                                
Conversion of Preferred Stock to common stock           $ 0         $ 0 [1]         128 [1]         0           128
Exercise of warrants (in shares)           0         10,000 [1]                                
Exercise of warrants           $ 0         $ 0 [1]         292 [1]         0   $ 292        
Reclassification of warrant liabilities           $ 0         $ 0 [1]         204,398 [1]         0           204,398
Other (in shares)           (1,000)         49,000 [1]                                
Other           $ (6)         $ 0         6         0           0
Issuance of common stock in at the market offering, net (in shares)         0         1,435,000                                  
Issuance of common stock in at the market offering, net         $ 0         $ 15         $ 13,379         $ 0           $ 13,394  
Stock-based compensation expense           $ 0         $ 0 [1]         25 [1]         0           25
Balance (in shares) at Mar. 31, 2026           0         26,717,000 [1]                                
Balance at Mar. 31, 2026           $ 0         $ 267 [1]         405,209 [1]         (266,651)           138,825
Balance (in shares) at Dec. 31, 2025 1,347,000         1,000         25,216,000 [1]                                
Balance at Dec. 31, 2025 $ 350         $ 6         $ 252 [1]         186,981 [1]         (819,054)           (631,815)
Net income (loss)                                                     511,333
Issuance of common stock in at the market offering, net (in shares)                                                   2,693,853  
Balance (in shares) at Jun. 30, 2026           0         50,591,000 [1]                                
Balance at Jun. 30, 2026           $ 0         $ 506 [1]         434,459 [1]         (307,721)           127,244
Balance (in shares) at Mar. 31, 2026           0         26,717,000 [1]                                
Balance at Mar. 31, 2026           $ 0         $ 267 [1]         405,209 [1]         (266,651)           138,825
Net income (loss)           $ 0         $ 0 [1]         0 [1]         (41,070)           (41,070)
Exercise of warrants (in shares)           0         22,615,000 [1]                                
Exercise of warrants           $ 0         $ 226 [1]         24,197 [1]         0           24,423
Issuance of common stock in at the market offering, net (in shares)         0         1,259,000                               1,258,934  
Issuance of common stock in at the market offering, net         $ 0         $ 13         $ 1,817         $ 0           $ 1,830  
Stock-based compensation expense           $ 0         $ 0 [1]         3,236 [1]         0           3,236
Balance (in shares) at Jun. 30, 2026           0         50,591,000 [1]                                
Balance at Jun. 30, 2026           $ 0         $ 506 [1]         $ 434,459 [1]         $ (307,721)           $ 127,244
[1] After giving retroactive effect to a 1-for-5 reverse stock split that became effective February 20, 2026.